Class 930 consists of two wholly separable parts, cross -reference
art collections 10-320 and digests 500-822. This class is intended
to be used as a searching area for patents which disclose an identifiable
peptide or protein sequence derived from at least four specified
named amino acids. Rules of placement into these areas vary, and
although any search in this class is optional, searching Class 930
is useful.
It should be noted that the patents in art collections 10-320
must contain an actual amino acid sequence. A patent containing
a reference, in name only, to a peptide or protein compound with
a known structure is not included. For example, though the amino
acid sequence of insulin is well-known, unless a sequence of at
least four amino acids from the insulin structure is shown in the
patent, it is not included in these art collections.
The following steps pertain to placement and search.
(1) Compounds containing a modified or unusual amino acid
(art collections 20 -25) are placed in all appropriate art collections.
(2) The sole presence of a nonpeptide or abnormal peptide
link in a linear peptide is not considered an indication of a modified
or unusual amino acid. (See art collection 30.)
(3) See only art collection 22 for halogen containing compounds
which are radioactive.
(4) The sulfur contained in the compounds of art collection
24 must be other than, or must be in addition to, that naturally
occurring in one or more of the natural amino acids, cysteine, cystine,
methionine.
(5) Art collection 30 does not include those peptides which
contain as the sole nonpeptide or abnormal peptide link, an interchain
disulfide bridge.
(6) Compounds included in art collections 200 (bacterial),
220 (parasitic), and 220-224 (viral0, are only those homologous
to the microorganism.
(7) Compounds containing a cys-cys disulfide bridge between
nonadjacent cysteine residues are placed in art collection 280 with
the exception of those compounds such as atrial natriuretic peptide,
vasopressin, or others containing disulfide bridges which are appropriate
for art collection 40-170.
(8) Art collection 270 does not include peptides or proteins
which are cyclic solely due to intrachain disulfide bridges, nor
does it include peptides or proteins which are appropriate for art
collections 40-170.
(9) Art collection 320 is incomplete. It is intended as a repository
for compounds which have been specifically modified to prevent enzymatic
degradation, but which are not more appropriately placed in any
of the other nonmainline art collections.
SECTION II - LINES WITH OTHER CLASSES AND WITHIN THIS CLASS
(A) CROSS-REFERENCE ART COLLECTIONS
Cross-reference art collections 10-320 are intended to be
used as a searching area for those patents which disclose an identifiable
peptide or protein consisting of a sequence of at least four amino
acids covalently bound through at least one normal peptide link.
Due to the nature of this class, it is important that it be considered
more as a term list than as a hierarchical schedule. The classification
rules of hierarchy do not apply unless otherwise specified in the
art collection definitions or unless specified by one art collection being
indented under another, i.e., art collections 21-25 are indented
under 20, art collections 141-145 are indented under 140.
Therefore, in this class, a peptide or protein compound is
placed in all art collections, regardless of order in the schedule,
where the concepts of the art collection definition include the
compound, unless otherwise specified.
(B) DIGESTS 500-822
Digests 500-822 are being established as U.S. classifications
and are equivalent to the European Patent Office"s C07K
5/00 - C07K 5/12B; C07K 7/02 - C07K 7/10B; C07K
7/50 - C07K 9/00F4; C07K 13/00; and C07K
99/00B - C07K 99/84 classifications.
The European Patent Office (EPO) uses a classification system
which is based upon the International Patent Classification (IPC)
system. The EPO allows its examiners to add "unofficial" or "alpha" classifications
to the IPC in a manner similar to our examiners adding "unofficial" or "alpha" classifications
to the U.S. Patent Classification system. With the addition of the "unofficials", the
IPC becomes the European Patent Classification (EPC) system.
As U.S. (and other countries) patents are published, the EPO
examiners receive them for placement into their search files. The
EPO examiners do not depend upon the IPCs printed on the issuing
documents for placement; they reclassify each document anew. As
a result of trilateral agreements, the U.S. regularly receives the
new classification data from the EPO. This classification data allows
us the capability to establish digests 500 - 822 as U. S. digests
which are equivalent to the EPO classifications recited in the first
paragraph and which contain the same U.S. patents which EPO examiners placed
into their files.
No definitions are associated with these digests. The full extent
of the types of documents intended to be classified in a digest
are the titles and any attached notes.
Digests 500-822 are the first areas in the U.S. classification
system which are resident in the Manual of Classification and present
a classification scheme wherein all of the patents have been classified
by another patent office into search areas created other than by
U.S. personnel.
The creation of digests 500-822 and their incorporation in
the Manual of Classification is a trial program to determine the
effectiveness of additional data bases which contain U.S. patents
as search areas. In addition this will be the first time that U.S.
examiners will be able to search EPC classifications. It is the
intent of Documentation to set up other areas of the EPC where it is
believed that a search area may be useful.
Digests 500-822 have been presented in a manner generally
consistent with the traditional presentation of search areas in
the U.S. Manual of Classification. In some instances areas in the
EPC have been omitted or arranged in a format to which U.S. examiners
are accustomed. In other instances the EPC classification does not
contain any U.S. patents. To complete a search of a concept in the
EPC it would be advisable to search both the generic subclass and
the more specific indented subclass.
Patents can be added to these classifications in the traditional
manner, i.e., blue slips, miscellaneous transfer, or 14B card. They
can be deleted by the present method of submitting a copy of the
document along with a request to classification.
At the end of each digest presented between parentheses is
the classification in the EPC which translates to the digest provided
for that EPC classification. To distinguish between the IPC and
EPC versions it is only necessary to note that the IPC does not
contain alpha designations. An example of this difference is digest 610,
which is denoted as C07K-99/22. Since the latter is devoid
of an alpha character it is both an IPC and EPC classification,
whereas C07K-99/22A (digest 611) has an alpha designator
and can only be found in the EPC. The use of a slash in the EPC
designation C07K-99/ is equivalent to the use of a color
in the IPC C07K-99 for this area
It is intended to maintain these digests in a form that reflects
the current status of the EPC. As patents are classified into the
EPC we will update the present digests to reflect the addition of
the newly added documents.
In digests 550-772 and 780-822, sequences modified by removal
or addition of amino acids, by substitution of amino acids by others,
or by a combination of these modifications, are classified as the
parent peptide when the combined number of modifications totals
less than 50% of the parent fragment. Fragments of these
peptides containing at least 5 amino acids, modified or not as mentioned
above, are classified as the parent peptide. In digests 590, 630,
and 680, the brackets have been used to indicate the presence of
a specified amino acid.
A glossary has been developed for Class 930 (section D of
the main class definition). Terms in the GLOSSARY have been used
consistently throughout the class. The following terms are applicable
only to digests 500-822.
(1) LINEAR PEPTIDES (DIGESTS 790-822) may comprise rings formed
through a hydroxy or a mercapto group of a hydroxy or a mercapto
amino acid and the carboxyl group of another amino acid, (e.g.,
peptide lactones, etc.) but do not comprise rings which are formed only
through peptide links.
(2) CYCLIC PEPTIDES (DIGESTS 532-549) are peptides comprising
at least one ring formed only through peptide links; the cyclisation
may occur only through normal or abnormal peptide links, e.g., through
the 4-amino group of 2,4-diamino-butanoic acid, etc. Cyclic compounds
in which at least one link in the ring is a nonpeptide link are
considered as linear peptides.
(C) AMINO ACID ABBREVIATIONS
For the purposes of all of Class 930, cross-reference art collections
10-320 and digests 500-822, the following amino acid abbreviations
are applicable:
Abbreviations and Amino Acid Names
Ala = Alanine; Arg = Arginine; Asn = Asparagine;
Asp = Aspartic Acid (Aspartate); Asx = Aspartic
Acid or Asparagine
For the purposes of all of Class 930, cross-reference
art collections 10-320 and digests 500-822, the following terms
are appropriate as defined:
AMINO ACIDS
Compounds in which at least one amino group and at least
one carboxyl group are bound to the same carbon skeleton and the
nitrogen atom of the amino group may form part of a ring.
NORMAL PEPTIDE LINK
Exists between an alpha-amino group of an amino acid and
the carboxyl group - in position 1 - of another alpha amino acid.
ABNORMAL PEPTIDE LINK
Exists between a nonalpha-amino group of an amino acid
and the carboxyl group - in position 1 - of an alpha-amino acid,
or between an alpha-amino group of one amino acid and the carboxyl
group - not in position 1 - of another amino acid.
PEPTIDES
Compounds containing a sequence of 4 to 100 amino acid
units, which are bound through at least one normal peptide link.
PROTEINS
Compounds containing an amino acid sequence of more than
100 amino acids, at least two of which are different, bound mostly
through normal peptide links.
Cross-reference art collection for a peptide or protein
consisting of an identifiable sequence of at least four amino acids
covalently bound through at least one normal peptide link into a backbone
structure.
(1)
Note. It should be noted that the patents included in this
and the indented art collections must contain an actual amino acid
sequence. A patent containing a reference, in name only, to a peptide
or protein compound with a known structure is not included. For
example, though the amino acid sequence of insulin is well-known,
unless a sequence of four or more amino acids from the insulin structure
are shown in the patent, the patent is not included in these art
collections.
(2)
Note. Rules of placement in Cross-Reference Art Collections
10-320: A compound is placed in ALL art collections, regardless
of hierarchy, where the definition concepts include the compound
in question, unless an art collection note excludes a compound from
one art collection after it has been placed in another. Therefore,
Class 930 provides a way of narrowing or fine-tuning computer searches
by the use of Boolean operators. As an example, art collection 21
(D-amino acid) can be connected with art collection 70 (corticotropin)
by using "and" in order to get a listing of patents
which may include corticotropin sequences containing D-amino acids. One
may alternatively use "not" and get a list of
the patents with corticotropin sequences containing no D-amino acids. As
another example, one may use "and" between art
collection 22 (radioactive atom) and art collection 60 (calcitonin) in
order to get a list of patents which may include radioactive calcitonin.
(3)
Note. Patents are placed in this and the indented art collections
according to the amino acid sequence or sequences disclosed in the
patent. In many cases these sequences may not be part of the claimed subject
matter but are disclosed in other parts of the patent.
(4)
Note. In many of the indented art collections the terminology "related
peptides" is used. Such a peptide can be one whose structure
corresponds to at least half the amino acid residues of the named
peptide, or one which is the product of side chain substitution,
C or N terminal chain extension and insertion, or a replacement reaction,
or a removal reaction. "Related peptides" also
encompasses functional analogues of the named compound. Such analogues
may also be placed in any of the other appropriate art collections.
Chemistry:
Natural Resins or Derivatives Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclasses 300 through 427for peptides and proteins and methods of making
and treating these peptides and proteins.
Subject matter under cross-reference art collection 10 for
peptides or proteins containing one or more modified or unusual
amino acids.
(1)
Note. The sole presence of a nonpeptide or abnormal peptide
link in a linear peptide is not considered an indication of a modified
or unusual amino acid.
(2)
Note. Examples of amino acids included in this subclass and
the indented subclasses are as follows:
Subject matter under cross-reference art collection 20 containing
a peptide or protein containing a sulfur other than a sulfur which
is merely a part of one of the natural amino acids, cysteine, cystine,
or methionine.
Subject matter under cross-reference art collection 10 containing
peptides or proteins which have a nonpeptide or abnormal peptide
link or bond joining two or more amino acid residues and do not
comprise rings which are formed through peptide links.
(1)
Note. Excluded from this art collection are compounds with
nonpeptide links due only to disulfide bridges joining two or more
sequences of amino-acid residues.
(2)
Note. This art collection includes peptide chains containing
nonpeptide moieties in the chain and chains in which the amino acid
residues are joined by a peptide bond formed by other than an alpha amino
acid. Examples include a compound like or gamma peptide bonding.
Chemistry: Natural
Resins or Derivatives; Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclass 323 for peptides with at least one nonpeptide bond
other than a disulfide bond and subclass 332 for a peptide containing
at least one abnormal peptide link.
Subject matter under cross-reference art collection 30 containing
a peptide or protein which is retro-inverted.
(1)
Note. Retro-inversion is a way of protecting peptide substances
against proteolysis. It entails retro-inverting those peptide bonds
most susceptible to enzymatic hydrolysis by inverting the direction
of the peptide bonds. The "retro-inverso peptides" are
structural isomers of the reference peptides and as such preserve
their biological activity while being more resistant to enzymatic hydrolysis.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to angiotensin and variations thereof,
synthetic and natural.
(1)
Note. Angiotensin is a pressor substance formed by the action
of renin on a plasma substrate, angiotensinogen.
(2)
Note. Included in this art collection are Angiotensin I, Angiotensin
II, and Angiotensinogen (hypertensinogen, renin substrate).
(3)
Note. Synonyms. Hypertensin, Angiotonin, Ang I, and Ang II.
(4)
Note. Search digest 590 for patents related to Angiotensin.
Chemistry: Natural
Resins or Derivatives; Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclass 316 for angiotensin and related peptides.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to atrial or brain natriuretic peptide
and variations thereof, synthetic and natural.
(1)
Note. ANP is a potent natriuretic, diuretic, and vasorelaxant
polypeptide.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to calcitonin and variations thereof,
synthetic and natural.
Chemistry: Natural
Resins or Derivatives; Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclass 307 for calcitonin and related peptides.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to corticotropins and variations thereof,
synthetic and natural.
(1)
Note. Corticotropin is a pituitary hormone which stimulates
release of adrenal cortical steroids and induces growth of adrenal
cortex.
Chemistry: Natural
Resins or Derivatives; Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclass 306 for corticotropin and related peptides.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to endorphin and enkephalin and variations thereof,
synthetic and natural.
(1)
Note. Endorphin and enkephalin are neuro-peptides which have
morphine-like activity.
(2)
Note. This art collection includes alpha-, beta-, and gamma-endorphins
and met- and leu-enkephalin.
(3)
Note. Synonyms. Endorphin: endogenous opiate, opiod peptide,
and LPH. Enkephalin: Morphine-like factor and pituitary opiate peptide.
(4)
Note. Search this class, digest 720 for patents related to
Beta-Endorphin and digest 740 for patents related to Enkephalin.
Chemistry: Natural
Resins or Derivatives; Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclass 302 for endorphin and enkephalin and related peptides.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to erythropoietin or variations thereof,
synthetic and natural.
(1)
Note. Erythropoietin is a circulating glycoprotein which stimulates
red blood cell formation in higher organisms.
(2)
Note. Synonyms. EPO, ESF, erythropoiesis stimulating factor,
and Ep.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to the blood coagulation Factor VIII,
also called antihemophilic factor, and variations thereof, synthetic
and natural.
(1)
Note. Physiological properties: Involved in the formation
of thromboplastin by the activation of factor X.
Chemistry: Natural
Resins or Derivatives; Peptides or Proteins; Lignins or Reaction
Products Thereof,
subclass 383 for factor VIII, AHF, and related peptides.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to the gonadotropins and variations
thereof, synthetic and natural.
(1)
Note. Gonadotropins stimulate the gonads to growth and production
of sex-specific hormones, i.e., estrogens and gestagens in the female
and androgens in the male.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to growth hormone, growth factor, or
growth hormone-releasing factor and variations thereof, synthetic
and natural.
(1)
Note. Since urogastrone is thought to be identical to epidermal
growth factor, this art collection is appropriate for urogastrone
amino acid sequences.
(2)
Note. Physiological properties: Growth hormone or factor:
promote growth of tissues. GH is also involved in regulation of
other phases of protein metabolism as well as fat, carbohydrate,
and mineral metabolism. GH-RF: helps mediate the neuro-regulation
of GH secretion.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to luteinizing hormone-releasing hormone
and variations thereof, synthetic and natural.
(1)
Note. LH-RH stimulates secretion of pituitary hormones LH
and FSH.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to lymphokines, and variations thereof,
synthetic and natural.
(1)
Note. Lymphokines are immune mediators produced by the cells
of the immune system.
(2)
Note. Included in this and the indented art collections are
interferon, interleukin and macrophage factors (monokines).
Subject matter under cross-reference art collection 140
containing peptides or proteins related to interleukin and variations
thereof, synthetic and natural.
(1)
Note. Interleukin is an immune mediatior which is a macrophage
derived factor that promotes short term proliferation of T-cells
(IL-1) or a lymphocyte derived factor that promotes long term proliferation
of T-cells in culture (IL-2).
(2)
Note. Synonyms. IL-1: LAF or leukocyte activating factor.
IL-2: TCGF or T-cell growth factor.
Subject matter under cross-reference art collection 140
containing peptides or proteins related to interferon and variations
thereof, synthetic and natural.
(1)
Note. Interferon is a protein elaborated by infected host
cells that protects noninfected cells from viral infection.
(2)
Note. This art collection includes alpha-IFN (leukocyte),
beta-IFN (fibroblast), and gamma-IFN (immune).
Subject matter under cross-reference art collection 140
containing peptides or proteins related to lymphotoxin (LT) and
variations thereof, synthetic and natural.
(1)
Note. Lymphotoxin is a lymphokine that results in direct cytolysis
following its release from stimulated lymphocytes. It can destroy
nonleucocyte target cells.
Subject matter under cross-reference art collection 140
containing peptides or proteins related to tumor necrosis factor
(TNF) and variations thereof, synthetic and natural.
(1)
Note. Tumor necrosis factor is a protein which is capable
of selective cytotoxicity against tumor cells.
Subject matter under cross-reference art collection 140
containing peptides or proteins related to colony stimulating factor
(CSF) and variations thereof, synthetic and natural.
(1)
Note. Colony stimulating factor is involved in the modulation
of the function of phagocytes and the regulation of other tissue.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to oxytocin and vasopressin and variations thereof,
synthetic and natural.
(1)
Note. Physiological properties: Oxytocin causes uterine contractions
and stimulates lactation. Vasopressin controls water metabolism
and contracts smooth muscle.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to somatostatin and variations thereof,
synthetic and natural.
(1)
Note. Physiological properties. Inhibits secretion of pituitary
growth hormone.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to vasoactive intestinal peptide and
variations thereof, synthetic and natural.
(1)
Note. Vasoactive Intestinal Peptide is a neuroactive gastrointestinal
hormone that relaxes systemic and vascular smooth muscle and stimulates
the exocrine pancreas, the secretion of insulin and of cyclic-AMP
formation in the small intestine.
(2)
Note. Synonyms. Vasoactive intestinal polypeptide and VIP.
Subject matter under cross-reference art collection 10 containing
peptides or proteins related to thymus derived hormones or factors
and variations thereof, synthetic and natural.
(1)
Note. Examples of thymus derived peptides include thymopoietin
(Thymin), thymosin, etc.
(2)
Note. Search this class, digest 750 for patents related to
thymopoietin.
Subject matter under cross-reference art collection 10 containing
peptides or proteins homologous to the bacteria and variations thereof, synthetic
and natural.
(1)
Note. A homologous polypeptide is one found in or produced
by the wild type (nontransformed) host microorganism.
Drug, Bio-Affecting
and Body Treating Compositions, 190.1 for a bacterial antigen-, epitope-, or other
immunospecific immunoeffector-containing body-treating composition
whose amino acid sequence is disclosed in whole or in part.
Subject matter under cross-reference art collection 10 containing
peptides or proteins which are homologous to the parasite and variations thereof,
synthetic and natural.
(1)
Note. See Note (1) under art collection 200 for the definition
of homologous.
Drug, Bio-Affecting
and Body Treating Compositions,
subclass 191.1 for a parasitic antigen-, epitope-, or other immunospecific
immunoeffecor-containing body-treating composition whose amnio acid
sequence is disclosed in whole or in part.
Subject matter under cross-reference art collection 10 containing
peptides or proteins homologous to the virus and variations thereof, synthetic
and natural.
(1)
Note. See Note (1) under art collection 200 for the definition
of homologous.
Drug, Bio-Affecting
and Body Treating Compositions,
subclasses 186.1+ for a viral antigen-, epitope-, or other immunospecific
immunoeffector-containing body-treating composition whose amino
acid sequence is disclosed in whole or in part.
Subject matter under cross-reference art collection 220
containing peptides or proteins related to the retrovirus, or the
human immunodeficiency virus (HIV), or the simian immunodificiency
virus (SIV) and variations thereof, synthetic and natural.
(1)
Note. Included in this art collection are viral sequences
related to human T-cell leukemia virus, human T-lymphotropic virus,
HTLV, HTLV-I, HTLV-II, HTLV-III, lymphadenopathy-associated virus, LAV,
AIDS-related virus, ARV, immune deficiency-associated virus, IDAV, STLV-I,
STLV-III, and viral sequences related to the disease states of acquired immune
deficiency syndrome, acquired immunodeficiency syndrome, AIDS, adult
T-cell leukemia-lymphoma, ATLL, Kaposi"s sarcoma, AIDS-related
complex, ARC, simian or mouse acquired immunodeficiency syndrome,
SAIDS, and MAIDS.
Drug, Bio-Affecting
and Body Treating Compositions,
subclass 187.1 and 188.1 for a retrovial (including immunodeficiency
viral) antigen-, epitope-, or other immunospecific immunoeffector-containing
body-treating composition whose amino acid sequence is disclosed
in whole or in part.
Subject matter under cross-reference art collection 220
containing peptides or proteins related to the Foot and Mouth Disease
Virus which is a small animal virus of the picornavirus family and
peptide variations thereof, synthetic and natural.
Subject matter under cross-reference art collection 220
containing peptides or proteins related to the hepatitis virus and
variations thereof, synthetic and natural.
Drug, Bio-Affecting
and Body Treating Compositions,
subclass 189.1 for a hepatitis viral antigen-, epitope-, or other
immunospecific immunoeffector-containing body-treating composition
whose amino acid sequence is disclosed in whole or in part.
Subject matter under cross-reference art collection 220
containing peptides or proteins related to the herpes virus and
variations thereof, synthetic and natural.
Subject matter under cross-reference art collection 10 containing
peptides or proteins derived from multicellular green or nongreen
plants and variations thereof, synthetic and natural.
Subject matter under cross-reference art collection 10 containing
peptides or proteins containing a cys-cys disulfide bridge between nonadjacent
cysteine residues such as in the case of at least one intrachain
disulfide bridge (cyclic) or at least one interchain disulfide bridge.
(1)
Note. This art collection contains only those compounds containing
a cys-cys disulfide bridge for which there are no appropriate named
compound art collections available (art collections 40-170) such
as those for ANP or vasopressin.
Subject matter under cross-reference art collection 10 containing
peptides or proteins which contain at least one ring formed through
a peptide or nonpeptide bond.
(1)
Note. In addition to the cyclic peptides containing at least
one ring formed only through peptide bonds, included in this subclass
are those cyclic compounds in which the peptide bond may be other than
that formed by the alpha amino nitrogen, e.g., through the 4-amino group
of 2,4 diamino butanoic acid and the cyclic compounds in which one
or more links in the ring are nonpeptide bonds (heterodectic cyclic
peptides).
(2)
Note. Excluded from this art collection are those compounds
which are cyclic because they contain intrachain disulfide bridges
and those compounds appropriate for art collections 40-170.
Subject matter under cross-reference art collection 10 containing
peptides or proteins which are bound to a nonpeptide drug, nonpeptide label,
nonpeptide carrier, or nonpeptide resin.
(1)
Note. Subject matter intended for this subclass includes peptides
coupled to luminol or a chromogenic indicator, peptide coupled to
a carrier to enhance antibody production, peptide coupled to an acrylamide
copolymer, peptide coupled to an antibiotic, etc.
Subject matter under cross-reference art collection 10 containing
a peptide or protein which is a polymer of the same amino acids
or is composed of a series of peptide repeating units.
(1)
Note. A series of peptide repeating units is intended to mean
that an amino acid sequence of two or more amino acid residues is
sequentially repeated two or more times in the peptide or protein
in uninterrupted sucession.
Subject matter under cross-reference art collection 10 containing
a peptide sequence denoted as a signal or leader.
(1)
Note. The terms signal or leader are usually associated with
the production of proteins by a recombinant microorganism. The signal
or leader sequence is an amino acid chain at the N-terminal end of
the protein which carries the protein out of the microbial cell.
Subject matter under cross-reference art collection 10 containing
a peptide sequence denoted as a linker sequence or peptide segment.
(1)
Note. Such linkers or segments are the connections for fused
polypeptides. The linker acts either as an enzyme cleavage site
or has physical and/or chemical characteristics which can
be used in isolation and/or purification of the expressed
protein.
Subject matter under cross-reference art collection 10 containing
a peptide or protein which has been modified to prevent enzymatic
degradation.
(1)
Note. This art collection is not complete. Only patents in
which the modification is a central part of the patent subject matter
are placed here except for those directed to retro-inversion.
Note: The Patent
and Trademark Depository Library Program (PTDLP) administers a nationwide
network of public, state and academic libraries designated as Patent and
Trademark Depository Libraries authorized by 35 U.S.C. 13 to: Disseminate
Patent and Trademark Information Support Diverse Intellectual Property
Needs of the Public. PTDL Contact Information
Note: For information/comments on electronic information products, such
as purchasing USPTO data, or to discuss system requirements for magnetic
tape products, contact:
KEY: =online
business system =fees =forms=help =laws/regulations =definition
(glossary)
The Inventors
Assistance Center is available to help you on patent
matters.Send questions about USPTO programs and services
to theUSPTO
Contact Center (UCC). You can suggest USPTO webpages
or material you would like featured on this section by E-mail
to the webmaster@uspto.gov.
While we cannot promise to accommodate all requests, your suggestions
will be considered and may lead to other improvements on the
website.